StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences r&d expenses

Research and development expenses are spending on new products and technology.

CV Sciences's R&D Expenses for the twelve months ending Sep 30, 2026 was $73.00K, down 43.4% year over year. For fiscal 2025 it was $122.00K, up 3.4% from the year before. Over ten years it grew -21.2% a year on average. The highest annual figure on record is $5.88M in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$122.00K+3.4%
FY2024Dec 31, 2024$118.00K-21.9%
FY2023Dec 31, 2023$151.00K-50.8%
FY2022Dec 31, 2022$307.00K-74.1%
FY2021Dec 31, 2021$1.19M-59.7%
FY2020Dec 31, 2020$2.94M-49.9%
FY2019Dec 31, 2019$5.88M+211.8%
FY2018Dec 31, 2018$1.89M+160.4%
FY2017Dec 31, 2017$724.00K-37.5%
FY2016Dec 31, 2016$1.16M-12.2%
FY2015Dec 31, 2015$1.32M+32.1%
FY2014Dec 31, 2014$999.28K+90.5%
FY2013Dec 31, 2013$524.48K–
FY2012Dec 31, 2012$0–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$19.00K-20.8%
Q2 FY2026Jun 30, 2026$18.00K-64.0%
Q1 FY2026Mar 31, 2026$18.00K-40.0%
Q4 FY2025Dec 31, 2025$18.00K-28.0%
Q3 FY2025Sep 30, 2025$24.00K-17.2%
Q2 FY2025Jun 30, 2025$50.00K+78.6%
Q1 FY2025Mar 31, 2025$30.00K-16.7%
Q4 FY2024Dec 31, 2024$25.00K-37.5%
Q3 FY2024Sep 30, 2024$29.00K-27.5%
Q2 FY2024Jun 30, 2024$28.00K-22.2%
Q1 FY2024Mar 31, 2024$36.00K+2.9%
Q4 FY2023Dec 31, 2023$40.00K0.0%
Q3 FY2023Sep 30, 2023$40.00K-9.1%
Q2 FY2023Jun 30, 2023$36.00K-64.7%
Q1 FY2023Mar 31, 2023$35.00K-71.1%
Q4 FY2022Dec 31, 2022$40.00K-89.0%
Q3 FY2022Sep 30, 2022$44.00K-89.3%
Q2 FY2022Jun 30, 2022$102.00K-54.7%
Q1 FY2022Mar 31, 2022$121.00K-34.9%
Q4 FY2021Dec 31, 2021$364.00K+31.9%
Q3 FY2021Sep 30, 2021$410.00K-0.5%
Q2 FY2021Jun 30, 2021$225.00K-69.8%
Q1 FY2021Mar 31, 2021$186.00K-87.7%
Q4 FY2020Dec 31, 2020$276.00K-78.8%
Q3 FY2020Sep 30, 2020$412.00K-73.3%
Q2 FY2020Jun 30, 2020$746.00K-55.8%
Q1 FY2020Mar 31, 2020$1.51M+12.4%
Q4 FY2019Dec 31, 2019$1.30M+71.4%
Q3 FY2019Sep 30, 2019$1.54M+191.3%
Q2 FY2019Jun 30, 2019$1.69M+281.9%
Q1 FY2019Mar 31, 2019$1.34M+771.4%
Q4 FY2018Dec 31, 2018$760.00K+405.7%
Q3 FY2018Sep 30, 2018$530.00K+195.5%
Q2 FY2018Jun 30, 2018$442.00K+114.9%
Q1 FY2018Mar 31, 2018$154.00K-18.4%
Q4 FY2017Dec 31, 2017$150.30K-46.2%
Q3 FY2017Sep 30, 2017$179.34K–
Q2 FY2017Jun 30, 2017$205.65K–
Q1 FY2017Mar 31, 2017$188.72K–
Q4 FY2016Dec 31, 2016$279.41K–

More CV Sciences figures

See a number that looks wrong?